Constipation resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 147: | Line 147: | ||
{{familytree | | | | | | | | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01=Normal transit constipation| A02=Slow transit constipation| A03=Pelvic floor dysfunction| A04= Combined slow transit constipation and pelvic floor dysfunction}} | {{familytree | | | | | | | | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01=Normal transit constipation| A02=Slow transit constipation| A03=Pelvic floor dysfunction| A04= Combined slow transit constipation and pelvic floor dysfunction}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree/end}} | |||
===Management of Normal Transit Constipation=== | |||
{{Family tree/start}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= Normal transit constipation}} | |||
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; height: 24em; width: 17em; padding:1em;">'''Fiber'''<br> | |||
---- | |||
❑ [[Psyllium]]: 1 tsp up to 3 times daily <br> '''OR''' <br> | |||
❑ [[Methylcellulose]]: 1 tsp up to 3 times daily<br>'''OR''' <br> | |||
❑ [[Calcium polycarbophil]]: 2-4 tablets OD <br> | |||
❑ Insoluble fiber (wheat bran) is not preferred <br> | |||
---- | |||
'''PLUS''' | |||
---- | |||
'''Saline laxative'''<br> | |||
---- | |||
❑ [[Milk of magnesia]]: 15-30 ml OD or BID <br></div>}} | |||
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | C01= Response to treatment}} | |||
{{familytree | | | | | | | | | | | | |,|-|-|^|-|-|.| | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | D01 | | | | D02 | | | | | | | | | | | D01=Yes | D02=No}} | |||
{{familytree | | | | | | | | | | | | |!| | | | | |!| | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | E01 | | | | E02 | | | | | | | | | | | E01= Continue the same regimen| E02=<div style="float: left; text-align: left; height: 11em; width: 14em; padding:1em;">'''Add stimulant laxative'''<br> | |||
---- | |||
❑ [[PEG]]: 8-32 oz once daily <br> '''OR''' <br> | |||
❑ [[Lactulose]]: 15-30 ml OD or BID</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | F01 | | | | | | | F01=Response to treatment}} | |||
{{familytree | | | | | | | | | | | | | | | |,|-|-|^|-|-|.| | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | G01 | | | | G02 | | | | G02=Yes| G01=No}} | |||
{{familytree | | | | | | | | | | | | | | | |!| | | | | |!| | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | H01 | | | | H02 | | | |H02=Continue the same regimen| H01=<div style="float: left; text-align: left; height: 14em; width: 14em; padding:1em;">'''Add hyperosmolar agents'''<br> | |||
---- | |||
❑ [[Bisacodyl]]: 10 mg suppositories or 5-10 mg orally up to 3 times/wk <br> '''OR''' <br> | |||
❑ [[Glycerin]]: Suppository OD</div>}} | |||
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | I01 | | | | | | | | |I01= Response to treament}} | |||
{{familytree | | | | | | | | | | | | |,|-|-|^|-|-|.| | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | J01 | | | | J02 | | | | | | |J01=Yes| J02=No}} | |||
{{familytree | | | | | | | | | | | | |!| | | | | |!| | | | |}} | |||
{{familytree | | | | | | | | | | | | H01 | | | | H02 | | | |H01=Continue the same regimen|H02=Adjust and change medications periodically}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree/end}} | {{familytree/end}} | ||
===Management of Slow Transit Constipation=== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 17:13, 10 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Definition
Constipation is a syndrome that is defined by unsatisfactory defecation characterized either by difficult stool passage that includes straining, sense of difficulty passing stool, incomplete evacuation, hard/lumpy stool, prolonged time to passage of stool, need for manual maneuvers to pass stool or by infrequent bowel movement or both.[1][2]
Rome III Criteria for Functional Constipation
Any 2 of the following |
---|
Less than three evacuations per week |
Lumpy or hard stools in ≥ 25% of defecations |
Straining during ≥ 25% of defecations |
Anorectal obstruction sensation for ≥ 25% of defecations |
Manual maneuvers to facilitate ≥ 25% of defecations |
Incomplete evacuation sensation for ≥ 25% of defecations |
Loose stools are not present |
Insufficient criteria for irritable bowel syndrome |
† Criteria fulfilled for the past 3 months and symptom onset atleast 6 months before diagnosis.[3]
American Gastroenterological Association, however have stopped using the term functional constipation because a subset these patients have slow colonic transit that has been associated with a marked reduction in colonic intrinsic nerves and interstitial cells of Cajal which is against the true definition of functional disorder.[4]
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Atropine poisoning
- Hypokalemia
- Lead poisoning
- Opium poisoning
- Severe dehydration
- Spinal cord injury
- Superior mesenteric artery occlusion
Common Causes
- Hardening of the feces: Improper mastication, low dietary fiber, dehydration and medications (aluminium, calcium, diuretic, iron).
- Paralysis or slowed transit: Hypothyroidism, hypokalemia, injured anal sphincter, medications (loperamide, codeine, morphine, tricyclic antidepressants) and severe systemic illness due to other causes.
- Constriction, where part of the intestine or rectum is narrowed or blocked: Diverticulosis, pelvic masses and stenosis.
- Psychosomatic constipation: Functional constipation and irritable bowel syndrome.[5]
- Smoking cessation[6]
- Abdominal surgery and childbirth
Management
The algorithm is based on the American Gastroenterological Association guidelines for management of constipation in adults.[7][2]
Initial Evaluation
Characterize the symptom: ❑ Any desire to defecate but an inability to pass a stool Associated symptoms: ❑ Abdominal pain or abdominal discomfort:
❑ Abdominal distention Obtain a detailed history: ❑ Dietary history: Dietary pattern change, low fiber diet, food intolerance, dehydration etc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ General status: Pulse, blood pressure, respiratory rate, weight, thyroid
❑ Abdominal examination: Mass, distension, tenderness and bowel sounds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order tests: ❑ Complete blood count (CBC) When secondary causes are suspected: ❑ Colonoscopy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Possible etiologies after initial evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Irritable bowel syndrome(IBS) | Unknown etiology | Organic constipation (mechanical obstruction or drug side effect) | Constipation secondary to systemic disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rx for IBS | Dietary fiber supplementation and simple laxatives | Treat the underlying etiology | Treat the underlying systemic disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refractory constipation if there is no response to initial management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Refractory Constipation
Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal BET, ARM, BD, CTT | Abnormal CTT Normal BET, ARM, BD | Abnormal BET, ARM, BD Normal CTT | Abnormal BET, ARM, BD, CTT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal transit constipation | Slow transit constipation | Pelvic floor dysfunction | Combined slow transit constipation and pelvic floor dysfunction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Normal Transit Constipation
Normal transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Saline laxative ❑ Milk of magnesia: 15-30 ml OD or BID | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treament | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | Adjust and change medications periodically | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Slow Transit Constipation
References
- ↑ American College of Gastroenterology Chronic Constipation Task Force (2005). "An evidence-based approach to the management of chronic constipation in North America". Am J Gastroenterol. 100 Suppl 1: S1–4. doi:10.1111/j.1572-0241.2005.50613_1.x. PMID 16008640.
- ↑ 2.0 2.1 Locke GR, Pemberton JH, Phillips SF (2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–6. PMID 11113098.
- ↑ Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561.
- ↑ Farrugia G (2008). "Interstitial cells of Cajal in health and disease". Neurogastroenterol Motil. 20 Suppl 1: 54–63. doi:10.1111/j.1365-2982.2008.01109.x. PMID 18402642.
- ↑ Caldarella MP, Milano A, Laterza F; et al. (2005). "Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion". Am. J. Gastroenterol. 100 (2): 383–9. doi:10.1111/j.1572-0241.2005.40100.x. PMID 15667496.
- ↑ "Nicotine withdrawal symptoms:Constipation". helpwithsmoking.com. 2005. Retrieved 2007-06-29.
- ↑ Bharucha AE, Pemberton JH, Locke GR (2013). "American Gastroenterological Association technical review on constipation". Gastroenterology. 144 (1): 218–38. doi:10.1053/j.gastro.2012.10.028. PMC 3531555. PMID 23261065.